Monsanto, The BioAg Alliance, and Novozyme have announced an updated research and development pipeline to improve crop harvests through products containing naturally-occurring microbes. Among the highlights is the Corn BioYield 2 project, which advanced to Phase 4 (pre-commercial) in The BioAg Alliance R&D pipeline and is expected to be branded as Acceleron B-360 ST, pending […]

All Monsanto 2017 corn hybrids sold in the United States will be treated with a new corn inoculant that showed a two-year average yield advantage of more than three bushels per acre. Monsanto and Novozymes through The BioAg Alliance have launched Acceleron B-300 SAT, derived from a fungus found in soil, and the first ‘upstream’ […]